Jeffrey Raich

Co-President, MD at Moelis & Company

Sits on 1 board. Last updated September 28, 2026

Time on boards

Boards served
1
Current seats
1
Board service
4 years
Director since
2023

4 years of board service in total across 1 board, counting each seat separately. Longest: Moelis & Company, 3 years.

Moelis & Company Director ยท Co-President, MD
3 years ยท Since 2023

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Feb 19, 2025 Moelis & Company Option exercise +18,758 โ€” โ€”
Feb 19, 2025 Moelis & Company Shares withheld for tax โˆ’1 $74.00 $41
Feb 19, 2025 Moelis & Company Open-market sale โˆ’8,722 $74.00 $645,428
Feb 18, 2025 Moelis & Company Option exercise +44,759 โ€” โ€”
Feb 29, 2024 Moelis & Company Open-market sale โˆ’44,710 $54.23 $2,424,623
Feb 23, 2024 Moelis & Company Open-market sale โˆ’45,093 $54.62 $2,462,980
Feb 21, 2024 Moelis & Company Option exercise +35,539 โ€” โ€”
Feb 21, 2024 Moelis & Company Option exercise +49,336 โ€” โ€”
Feb 21, 2024 Moelis & Company Shares withheld for tax โˆ’1 $52.60 $63
Feb 21, 2024 Moelis & Company Open-market sale โˆ’39,781 $52.60 $2,092,481
Feb 22, 2023 Moelis & Company Option exercise +58,496 โ€” โ€”
Feb 22, 2023 Moelis & Company Shares withheld for tax โˆ’10,180 $42.06 $428,164
Feb 22, 2023 Moelis & Company Option exercise +32,986 โ€” โ€”
Feb 22, 2023 Moelis & Company Open-market sale โˆ’36,592 $42.06 $1,539,060
Feb 13, 2023 Moelis & Company Open-market sale โˆ’17,183 $45.08 $774,610

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.